These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6109333)

  • 21. Occurrence of extended-spectrum (beta)-lactamases and plasmid-mediated AmpC (beta)-lactamases among Korean isolates of Proteus mirabilis.
    Park YJ; Lee S; Kim YR; Oh EJ; Woo GJ; Lee K
    J Antimicrob Chemother; 2006 Jan; 57(1):156-8. PubMed ID: 16284101
    [No Abstract]   [Full Text] [Related]  

  • 22. [A study on the determination method of biological function of BRF].
    Xu Q; Yuan Z; Wang Y; Liu J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Jun; 17(2):233-4, 237. PubMed ID: 12557788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of Proteus mirabilis strains in clinical specimens and evaluation of their resistance to selected antibiotics].
    Sekowska A; Janicka G; Wróblewska J; Kruszyńska E
    Pol Merkur Lekarski; 2004 Nov; 17(101):538-40. PubMed ID: 15754653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observations on the action of benzylpenicillin on a strain of Streptococcus lactis.
    Dring GJ; Hurst A
    J Gen Microbiol; 1969 Feb; 55(2):185-94. PubMed ID: 5190528
    [No Abstract]   [Full Text] [Related]  

  • 25. [Investigations on antibacterial activity of apalcillin].
    Stille W; Helm E; Mielenz H
    Arzneimittelforschung; 1982; 32(9):1128-30. PubMed ID: 6816250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
    Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K
    Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth inhibition of Proteus mirabilis by cyclic adenosine 3'-5'-monophosphate.
    Schwarzhoff RH; Williams FD
    J Bacteriol; 1976 Sep; 127(3):1590-2. PubMed ID: 182676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
    Yong D; Lim YS; Roh KH; Choi YS; Park DY; Yum JH; Kim JM; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of Proteus mirabilis and its L-phase variant to thallium acetate.
    Watanabe T; Fujita O; Horikawa T
    Bull Tokyo Med Dent Univ; 1971 Dec; 18(4):311-7. PubMed ID: 4948564
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
    J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of benzylpenicillin and doxycycline on toxicity and antineoplastic action of cyclophosphamide and methotrexate in mice].
    Pakulska W
    Acta Pol Pharm; 1992; 49(1-2):35-40. PubMed ID: 8769079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Penicillinase activity of staphylococci and their sensitivity to penicillin G and oxacillin (author's transl)].
    Aktaş F; Ata H; Altay G
    Mikrobiyol Bul; 1980 Jan; 14(1):27-31. PubMed ID: 6969841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the present in vitro-susceptibility of N. meningitidis to benzyl-penicillin. A survey based on 82 fresh isolates from bacterial carriers belonging to the German Army (author's transl)].
    Korting HC; Haag R
    Zentralbl Bakteriol A; 1980; 248(1):129-33. PubMed ID: 6781165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-beta-lactamase VIM-1 in Greece.
    Galani I; Souli M; Koratzanis E; Koratzanis G; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 2007 Mar; 59(3):578-9. PubMed ID: 17255145
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.
    Song W; Jeong SH; Kim JS; Kim HS; Shin DH; Roh KH; Lee KM
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):315-8. PubMed ID: 17174510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential integration sites of the Salmonella genomic island 1 in Proteus mirabilis and other bacteria.
    Doublet B; Golding GR; Mulvey MR; Cloeckaert A
    J Antimicrob Chemother; 2007 Apr; 59(4):801-3. PubMed ID: 17293370
    [No Abstract]   [Full Text] [Related]  

  • 37. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase.
    Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Pournaras S; Markou F
    J Antimicrob Chemother; 2007 Jul; 60(1):136-9. PubMed ID: 17491004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laser interferometric and cultivation methods for measurement of colistin/ampicilin and saponin interactions with smooth and rough of Proteus mirabilis lipopolysaccharides and cells.
    Arabski M; Wasik S; Dworecki K; Kaca W
    J Microbiol Methods; 2009 May; 77(2):178-83. PubMed ID: 19318050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.
    D'Andrea MM; Nucleo E; Luzzaro F; Giani T; Migliavacca R; Vailati F; Kroumova V; Pagani L; Rossolini GM
    Antimicrob Agents Chemother; 2006 Feb; 50(2):618-24. PubMed ID: 16436718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Phagocytosis of cell wall defective bacteria by human macrophages (author's transl)].
    Koller H; Adam D; Daschner F
    Med Microbiol Immunol; 1975; 161(2):107-12. PubMed ID: 1095903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.